ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,561Medicare Part D Prescriptions Filled, Including Refills

Rank: 150 out of 670

$579K Total Retail Price of All Prescriptions

Rank: 145 out of 670

253 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 253 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,430 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 557 523 1 2
WARFARIN SODIUM 534 451 2 13
FUROSEMIDE 417 405 3 6
POTASSIUM CHLORIDE 341 296 4 16
LISINOPRIL 271 243 5 3
OMEPRAZOLE 221 173 6 5
METOPROLOL TARTRATE 214 184 7 9
SIMVASTATIN 201 172 8 4
SERTRALINE HCL 159 133 9 22
HYDROCODONE-ACETAMINOPHEN 157 152 S3 10 1
NAMENDA 147 137 11 54
METFORMIN HCL 135 124 12 8
POLYETHYLENE GLYCOL 3350 132 130 13 79
CLOPIDOGREL 130 130 14 24
ATENOLOL 115 113 15 17
NEXIUM 111 98 16 14
GABAPENTIN 108 86 17 11
METOPROLOL SUCCINATE 107 91 18 12
HYDROCHLOROTHIAZIDE 105 95 19 10
DONEPEZIL HCL 96 96 20 31
RANITIDINE HCL 96 73 20 25
PLAVIX 92 92 22 34
CITALOPRAM HBR 89 75 23 20
AMLODIPINE BESYLATE 87 87 24 7
TRAMADOL HCL 82 72 25 21
LANTUS 78 65 26 58
CIPROFLOXACIN HCL 74 68 27 60
LANSOPRAZOLE 72 59 28 86
PHENYTOIN SODIUM EXTENDED 70 60 29 135
CRESTOR 66 66 30 18
ACETAMINOPHEN-CODEINE 66 66 S3 30 119
PREDNISONE 64 64 32 40
ALLOPURINOL 62 62 33 38
DIGOXIN 61 61 34 46
FENOFIBRATE 60 48 35 64
ATORVASTATIN CALCIUM 59 50 36 15
CARVEDILOL 58 58 37 29
LOVASTATIN 56 31 38 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 52 39 93
TRIAMTERENE-HCTZ 55 53 39 69
ZOLPIDEM TARTRATE 55 48 39 23
RISPERIDONE 54 54 42 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.